These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15217702)

  • 1. [Recommendations for the cytogenetic management of chronic myeloid leukemia (CML) proposed by the French Group for Cytogenetic Hematology].
    Dastague N;
    Pathol Biol (Paris); 2004 Jun; 52(5):238-40. PubMed ID: 15217702
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recommendations for the cytogenetic management of myeloproliferative syndromes proposed by the French Group for Cytogenetic Hematology].
    Groupe Français de Cytogénétique Hématologique (GFCH)
    Pathol Biol (Paris); 2004 Jun; 52(5):241-4. PubMed ID: 15217703
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recommendations for the cytogenetic management of acute myeloblastic leukemia established by the French Group for Cytogenetic Hematology].
    Groupe Français de Cytogénétique Hématologique (GFCH)
    Pathol Biol (Paris); 2004 Jun; 52(5):248-50. PubMed ID: 15217705
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recommendations for the cytogenetic management of chronic lymphocytic leukemia established by the French Group for Cytogenetic Hematology].
    Groupe Français de Cytogénétique Hématologique (GFCH)
    Pathol Biol (Paris); 2004 Jun; 52(5):254-6. PubMed ID: 15217707
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recommendations for the cytogenetic management of adult and childhood acute lymphoblastic leukemia (ALL) proposed by the French Group for Cytogenetic Hematology].
    Groupe Français de Cytogénétique Hématologique (GFCH)
    Pathol Biol (Paris); 2004 Jun; 52(5):251-3. PubMed ID: 15217706
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recommendations for the cytogenetic management of multiple myeloma proposed by the French Group for Cytogenetic Hematology]].
    Groupe Français de Cytogénétique Hématologique (GFCH)
    Pathol Biol (Paris); 2004 Jun; 52(5):263-4. PubMed ID: 15217710
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recommendations for the cytogenetic management of myelodysplastic syndrome by the French Group fo Cytogenetic Hematology].
    Groupe Français de Cytogénétique Hématologique (GFCH)
    Pathol Biol (Paris); 2004 Jun; 52(5):245-7. PubMed ID: 15217704
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recommendations for the cytogenetic management of non-Hodgkin lymphoma in children <18 years old proposed by the French Group for Cytogenetic Hematology].
    Groupe Français de Cytogénétique Hématologique (GFCH)
    Pathol Biol (Paris); 2004 Jun; 52(5):257-9. PubMed ID: 15217708
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recommendations for the cytogenetic management of adult malignant non-Hodgkin lymphoma proposed by the French Group for Cytogenetic Hematology].
    Groupe Français de Cytogénétique Hématologique (GFCH)
    Pathol Biol (Paris); 2004 Jun; 52(5):260-2. PubMed ID: 15217709
    [No Abstract]   [Full Text] [Related]  

  • 10. [Introduction to recommendations for the cytogenetic management of hematopoietic diseases].
    Dastugue N;
    Pathol Biol (Paris); 2004 Jun; 52(5):235-7. PubMed ID: 15217701
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytogenetics in the management of "chronic myeloid leukemia": an update by the Groupe francophone de cytogénétique hématologique (GFCH).
    Roche-Lestienne C; Boudry-Labis E; Mozziconacci MJ
    Ann Biol Clin (Paris); 2016 Oct; 74(5):511-515. PubMed ID: 27477825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytogenetic studies in chronic myeloid leukemia].
    Balázs C; Bobory J; Nagy G; Petrányi G
    Orv Hetil; 1975 Apr; 116(16):918-24. PubMed ID: 1054476
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of chronic myeloid leukemia in France: a multicentered cross-sectional study on 538 patients.
    Tardieu S; Brun-Strang C; Berthaud P; Michallet M; Guilhot F; Rousselot P; Sambuc R
    Pharmacoepidemiol Drug Saf; 2005 Aug; 14(8):545-53. PubMed ID: 15534856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of cytogenetic studies in chronic granulocytic leukemia].
    Oláh E; Kiss A; Jákó J
    Orv Hetil; 1980 Aug; 121(32):1933-9. PubMed ID: 6935618
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between autoradiographic, cytochemical and cytogenetic findings in chronic myeloid leukaemia.
    Quaglino D; Emilia G; Piccinini L; De Pasquale A; Zanni G; Guerzoni O; Giuliani M
    Haematologica; 1977 Aug; 62(4):360-77. PubMed ID: 409645
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cytogenetic and clinical study of myeloid leukemia].
    Jiang SH; Shi WY; Liu H; Song GQ; Sun GX; Lu W; Liu DF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):571-3. PubMed ID: 17922430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic myelogenous leukemia. Correlation between clinical, laboratory and cytogenetic data (author's transl)].
    Lisker R; Pérez-Chávez F; Casas L; Córdova MS; Mutchinick O
    Rev Invest Clin; 1980; 32(2):187-92. PubMed ID: 6932688
    [No Abstract]   [Full Text] [Related]  

  • 18. Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?
    Larson RA
    Best Pract Res Clin Haematol; 2007 Mar; 20(1):29-37. PubMed ID: 17336252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced-intensity conditioning for allogeneic stem cell transplantation in patients with chronic myeloid leukemia is associated with better overall survival but inferior disease-free survival when compared with myeloablative conditioning - a retrospective study of the Czech National Hematopoietic Stem Cell Transplantation Registry.
    Faber E; Koza V; Vitek A; Mayer J; Sedlacek P; Zak P; Zapletalova J; Benesova K; Krejcova H; Steinerova K; Maresova I; Cetkovsky P;
    Neoplasma; 2007; 54(5):443-6. PubMed ID: 17688375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parameters for predicting allogeneic PBSCT outcome of acute myeloid leukemia: cytogenetics at presentation versus disease status at transplantation.
    Kim DH; Sohn SK; Kim JG; Lee NY; Sung WJ; Baek JH; Suh JS; Lee KS; Lee KB
    Ann Hematol; 2005 Jan; 84(1):25-32. PubMed ID: 15349754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.